Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys.
about
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirusViable polioviruses that encode 2A proteins with fluorescent protein tags.A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic.Addition of a foreign oligopeptide to the major capsid protein of poliovirusA novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein.Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitisPolioviruses containing picornavirus type 1 and/or type 2 internal ribosomal entry site elements: genetic hybrids and the expression of a foreign geneCrystal structures of enterovirus 71 (EV71) recombinant virus particles provide insights into vaccine design.Recombinant Encephalomyocarditis Viruses Elicit Neutralizing Antibodies against PRRSV and CSFV in MiceCrystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.Theiler's virus as a vector for foreign gene delivery.Host range determinants located on the interior of the poliovirus capsidEngineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for miceUse of random systematic mutagenesis to generate viable human rhinovirus 14 chimeras displaying human immunodeficiency virus type 1 V3 loop sequences.Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytesVaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV.Replication of poliovirus RNA containing two VPg coding sequences leads to a specific deletion eventChimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs.Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1.Infectious enveloped RNA virus antigenic chimerasImproved distribution of antigenic site specificity of poliovirus-neutralizing antibodies induced by a protease-cleaved immunogen in miceAn antigen chimera of poliovirus induces antibodies against human papillomavirus type 16Chimeric picornavirus polyproteins demonstrate a common 3C proteinase substrate specificityConstruction of a poliovirus type 1/type 2 antigenic hybrid by manipulation of neutralization antigenic site II.Mutational analysis of the genome-linked protein VPg of poliovirus.Increasing Type 1 Poliovirus Capsid Stability by Thermal Selection.Expression of foreign proteins by poliovirus polyprotein fusion: analysis of genetic stability reveals rapid deletions and formation of cardioviruslike open reading frames.Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses.Mapping of a neutralizing antigenic site of Coxsackievirus B4 by construction of an antigen chimera.Genetic variation occurring on the genome of an in vitro insertion mutant of poliovirus type 1.Evidence suggesting that virulence maps to the P1 region of the coxsackievirus B4 genome.In vitro disassembly of a parvovirus capsid and effect on capsid stability of heterologous peptide insertions in surface loops.The yellow fever 17D vaccine virus: molecular basis of viral attenuation and its use as an expression vector.Three-dimensional structure of a mouse-adapted type 2/type 1 poliovirus chimera.Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I.Thermal stability of RNA phage virus-like particles displaying foreign peptidesInsertion of short hepatitis virus A amino acid sequences into poliovirus antigenic determinants results in viable progeny.
P2860
Q27696730-01986B1F-6F81-4F1F-B938-8A69C780F424Q30382863-028652C5-BDCB-4F37-B1FE-4CCF6FFCBB41Q33611894-EA872EA5-1C4D-4E87-8A13-103634CC1F59Q33672096-FF20FB31-FA88-44E5-A6F5-EB3DB7BE2DCBQ33685512-D303C511-EC33-43FB-92F0-DEBA564C7E95Q34349295-4AC603A5-3762-4CD9-B987-D5E23F8AD4C1Q35047782-9005E0C9-B707-4FDF-89A2-0DAA2622F5B2Q35055458-5D286691-2EE2-4882-BCFE-CE8B8D95A3DFQ35744528-D9CBDB9E-BDF9-4A5E-B67C-1BAE1ED533DBQ35760496-40A5877E-644E-4B38-8BB7-E87FF9C2A05AQ35839151-70605204-8CAD-49E6-B6F5-5301D015F027Q35924424-AB0BC05D-66E1-4EE7-99A1-C19AE23F0F63Q36062193-627ED333-A139-4B7E-9E27-B190076DAE97Q36620984-10F2F937-D775-41A2-9EF0-FB598F7DDEC2Q36633955-10CE931C-73AE-442A-B28E-1DB71A125384Q36636915-B10A99F7-B6E6-4606-979E-14AD96F2F514Q36652292-3262A2E8-5962-469B-9FFF-BEE305595C83Q36694642-A04C2F64-B6C6-4B66-8E57-6C1B34C13ACAQ36697629-093EE2D0-2E82-47E2-BADC-F8434F7C003CQ36764353-AF76AE3E-18CA-4DE5-A2B9-470556C689D7Q36800388-B78F3015-26ED-456C-BCF5-5715A13B9235Q36802227-9161A236-5E2C-449B-9D6E-0570E713D3D5Q36829933-8B543DAA-ED09-4680-93FA-8667CD46B0A0Q36832245-B8A8AD64-2C7C-4E8D-BE55-B1DFB6310D45Q36882054-5B174A11-260B-4DC9-9830-AEE11FF2BFEFQ37618759-FF469EC7-8320-48D3-B179-539F61E36D01Q39577039-3113EDA0-B5FA-4EB3-84D9-5A323330777DQ40041072-DD89C085-2264-47A1-84A5-25F3EF996087Q40066821-D689793A-8663-49CE-A96B-D5A0FE824718Q40100675-4642746D-3C70-494E-A542-4E4E706C430BQ40109419-C938C0DE-3202-48CD-BE11-86369257AB0DQ40609806-84D51BCD-9BD3-4213-AF82-50DE1B54D3FAQ40655554-C0A571CA-A51B-4E50-8B60-21F81B37B5E2Q41081945-836AD7E5-D39C-42B8-BC46-A613477F3481Q41903253-B64E9621-5C94-4FB7-9588-96849030086EQ42764128-4A67D224-7C56-404A-8932-F3921A3DBDF1Q45846985-244F4DA2-D2AF-4DA8-A4DB-42AC2C0BACDE
P2860
Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys.
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Poliovirus type 1/type 3 antig ...... bodies in rabbits and monkeys.
@ast
Poliovirus type 1/type 3 antig ...... bodies in rabbits and monkeys.
@en
Poliovirus type 1/type 3 antig ...... bodies in rabbits and monkeys.
@nl
type
label
Poliovirus type 1/type 3 antig ...... bodies in rabbits and monkeys.
@ast
Poliovirus type 1/type 3 antig ...... bodies in rabbits and monkeys.
@en
Poliovirus type 1/type 3 antig ...... bodies in rabbits and monkeys.
@nl
prefLabel
Poliovirus type 1/type 3 antig ...... bodies in rabbits and monkeys.
@ast
Poliovirus type 1/type 3 antig ...... bodies in rabbits and monkeys.
@en
Poliovirus type 1/type 3 antig ...... bodies in rabbits and monkeys.
@nl
P2093
P2860
P356
P1476
Poliovirus type 1/type 3 antig ...... bodies in rabbits and monkeys.
@en
P2093
P2860
P304
P356
10.1073/PNAS.85.9.3203
P407
P577
1988-05-01T00:00:00Z